April 26, 2024

• 

[THE INVESTOR] As of Jan. 20 11:55 A.M., Genic declined 1.81% from yesterday, to 13,600 won (US$ 11.56). It declined 6.34% over the past month. Standard deviation for the one month period stood at 2.8%.

Compared with industry competitors listed on the KOSDAQ, as the monthly volatility of Genic relatively expanded, the investment return for one month period was negative.

The monthly return-on-risk, indicating the return on investment with consideration for risk, was -2.2. As high volatility and a bearish stock price trend, the return-on-risk recorded a low value. Compared with the rest of the KOSDAQ industry, the return-on-risk was below the industrial mean, 0.6.

■ Earnings & Valuation

Genic (123330)
Earning reports for 3Q(July ~ Sept) of 2016
Revenue: 211.4 T   Down 25.4% on-quarter, up 6.2% on-year 
Operating income: 14.7 T    Down 63.2% on-quarter, up 166.4% on-year
Net income: 7.7 T   Up 28.5% on-quarter, up 60.6 % on-year

Investor Groups (Over the past five trading days)
Institutions 7.53%, Foreigners 8.45%, Individuals 84.01%

* Other investor groups including corporations are considered as “individuals”.

By HeRo (hero@heraldcorp.com)

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.